Effect of prior chemotherapy on survival in patients from the randomized phase III J-ALEX study of alectinib versus crizotinib in ALK-positive non-small cell lung cancer
Tetsuya Mitsudomi, Makoto Nishio, Kazuhiko Nakagawa, Nobuyuki Yamamoto et autres
0 citationsInternational Journal of Lung Cancer